0001415889-24-018977.txt : 20240702 0001415889-24-018977.hdr.sgml : 20240702 20240702173150 ACCESSION NUMBER: 0001415889-24-018977 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240701 FILED AS OF DATE: 20240702 DATE AS OF CHANGE: 20240702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DIORIO CHRIS PH.D. CENTRAL INDEX KEY: 0001677721 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37824 FILM NUMBER: 241097251 MAIL ADDRESS: STREET 1: 400 FAIRVIEW AVENUE NORTH STREET 2: SUITE 1200 CITY: SEATTLE STATE: WA ZIP: 98109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMPINJ INC CENTRAL INDEX KEY: 0001114995 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC COMPONENTS, NEC [3679] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 912041398 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 FAIRVIEW AVENUE NORTH STREET 2: SUITE 1200 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-517-5300 MAIL ADDRESS: STREET 1: 400 FAIRVIEW AVENUE NORTH STREET 2: SUITE 1200 CITY: SEATTLE STATE: WA ZIP: 98109 4 1 form4-07022024_090747.xml X0508 4 2024-07-01 0001114995 IMPINJ INC PI 0001677721 DIORIO CHRIS PH.D. 400 FAIRVIEW AVENUE NORTH SUITE 1200 SEATTLE WA 98109 true true false false CHIEF EXECUTIVE OFFICER 1 Common Stock 2024-07-01 4 M 0 5000 22.40 A 294474 D Common Stock 2024-07-01 4 S 0 889 151.4035 D 293585 D Common Stock 2024-07-01 4 S 0 392 152.2533 D 293193 D Common Stock 2024-07-01 4 S 0 1385 153.3735 D 291808 D Common Stock 2024-07-01 4 S 0 409 154.6645 D 291399 D Common Stock 2024-07-01 4 S 0 1093 155.554 D 290306 D Common Stock 2024-07-01 4 S 0 832 156.4343 D 289474 D Common Stock 2024-07-02 4 M 0 5000 22.40 A 294474 D Common Stock 2024-07-02 4 S 0 1083 154.5485 D 293391 D Common Stock 2024-07-02 4 S 0 3567 155.6878 D 289824 D Common Stock 2024-07-02 4 S 0 350 156.34 D 289474 D Common Stock 552494 I by DFT L.L.C. Stock Option (right to buy) 22.40 2024-07-01 4 M 0 5000 0 D 2028-06-15 Common Stock 5000 85536 D Stock Option (right to buy) 22.40 2024-07-02 4 M 0 5000 0 D 2028-06-15 Common Stock 5000 80536 D The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan effective on February 28, 2024. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $150.84 to $151.83, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $151.975 to $152.855, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $153.045 to $153.905, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $154.09 to $154.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $155.265 to $156.025, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $156.32 to $156.6775, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $154.25 to $155.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $155.25 to $156.245, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. The option became fully vested on June 11, 2022. /s/ Yukio Morikubo, Attorney in fact for Chris Diorio 2024-07-02